11 Best Drug Stocks to Buy According to Hedge Funds

Page 8 of 10

3. Intuitive Surgical, Inc. (NASDAQ:ISRG)

Number of Hedge Fund Holders: 106

Intuitive Surgical, Inc. (NASDAQ:ISRG) is one of the 11 Best Drug Stocks to Buy According to Hedge Funds. On June 10, William Blair analyst Brandon Vazquez maintained their bullish stance on Intuitive Surgical, Inc. (NASDAQ:ISRG), giving it a Buy rating. The analyst based the optimistic rating on the company’s present market position and future prospects.

Although concerns exist that remanufactured instruments may potentially impact growth, the analyst believes that the absence of third-party verification participation and the restricted availability of FDA-cleared remanufactured instruments are expected to hinder their widespread adoption.

He also reasoned that robotics programs are costly and often carry risks, which is why hospitals may be cautious about operating outside Intuitive Surgical, Inc.’s (NASDAQ:ISRG) ecosystem. This hesitant approach could deal with the effects of remanufacturing concerns on the company’s operations.

While the analyst acknowledges that there are risks that need to be monitored, Intuitive Surgical, Inc. (NASDAQ:ISRG) has solid overall fundamentals that support the optimistic rating. The company is the third best drug stock to buy now according to hedge funds.

Intuitive Surgical, Inc. (NASDAQ:ISRG) has an elaborate ecosystem of services and products that provides robotic-assisted surgical solutions and invasive care. Its products include the Ion Endoluminal and the Da Vinci Surgical systems.

Page 8 of 10